{
    "Trade/Device Name(s)": [
        "cobas\u00ae Cdiff Test"
    ],
    "Submitter Information": "Roche Molecular Systems, Inc.",
    "510(k) Number": "K142422",
    "Predicate Device Reference 510(k) Number(s)": [
        "K130470"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZN",
        "OOI"
    ],
    "Summary Letter Date": "April 16, 2015",
    "Summary Letter Received Date": "April 17, 2015",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3130",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Clostridium difficile toxin gene amplification assay",
        "Real Time Nucleic Acid Amplification System"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Clostridium difficile toxin B (tcdB) gene"
    ],
    "Specimen Type(s)": [
        "Unformed stool",
        "Liquid stool",
        "Soft stool"
    ],
    "Specimen Container(s)": [
        "cobas\u00ae PCR Media and Swab Sample Kit"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas\u00ae 4800 System",
        "cobas x 480 Instrument",
        "cobas z 480 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time polymerase chain reaction (PCR)",
        "TaqMan fluorescence detection",
        "Automated sample preparation",
        "Nucleic acid extraction"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Real-time PCR"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Reagent",
        "Control",
        "Buffer",
        "Sample preparation",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Roche cobas\u00ae Cdiff Test, a qualitative automated PCR assay for detection of Clostridium difficile toxin B gene in unformed stool using the cobas\u00ae 4800 System.",
    "Indications for Use Summary": "Automated, qualitative in vitro diagnostic test for direct detection of the toxin B (tcdB) gene of toxigenic Clostridium difficile in unformed stool specimens from patients suspected of C. difficile infection; intended as aid in diagnosis in conjunction with clinical and epidemiological risk factors.",
    "fda_folder": "Microbiology"
}